Clinical Trials Logo
  1. Home
  2. Infectious Disease
  3. NCT05507086
  4. Details
NCT05507086 Clinical Trial

Infectious Pseudochromdrosis Caused by Bacillus Cereus

Infectious Disease Clinical Trial

— Blue sweat  

Official title:
Blue Sweat - Infectious Pseudochromdrosis Caused by Bacillus Cereus

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05507086
Other study ID # IPCH2
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date December 31, 2023

Study information
Verified date August 2022
Source Oslo University Hospital
Contact Christoffer A Ingvaldsen, MD PhD
Phone 004741271030
Email aamingvaldsen@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Twelve patients with blue sweat (infectious pseudochromhidrosis) caused by Bacillus cereus.

Description:

Case series/observational study. Twelve patients with blue sweat (infectious pseudochromhidrosis) caused by Bacillus cereus. Demography, clinical presentation, diagnosis, treatments, microbiology and causality.

Recruitment information / eligibility
Status Recruiting
Enrollment 12
Est. completion date December 31, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Infectious pseudochromhidrosis caused by Bacillus cereus Exclusion Criteria: - Other types of blue chromhidrosis

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Antimicrobial therapy
Antimicrobial therapy

Locations
Country Name City State
Norway Department of Microbiology Lørenskog Viken

Sponsors (1)
Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome
Type Measure Description Time frame Safety issue
Primary Remission Descriptive / physical examination 1 year
Primary Repeated bacteriological swab Repeated bacteriological swab if uncertainty in terms of complete remission 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05568953 - An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity Phase 2
Completed NCT04568889 - Minnesota COVID-19 Testing Project N/A
Completed NCT06063330 - Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects Phase 1
Completed NCT01198925 - Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion Phase 4
Completed NCT05063812 - Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
Not yet recruiting NCT03636711 - Antibiotic Stewardship in Infectious Disease Departement
Completed NCT03457688 - Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children N/A
Completed NCT03241355 - Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children N/A
Terminated NCT05420077 - Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273 Phase 1
Completed NCT04084106 - Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota Phase 4
Recruiting NCT05013944 - AnovaOS Network Powered Patient Registry
Completed NCT03893279 - Perception of Smell and Taste During Antibiotic Treatment
Active, not recruiting NCT05619770 - Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects Phase 1
Completed NCT01772901 - Brief Influenza Vaccine Education to Pregnant Women N/A
Completed NCT05413772 - Temocillin in ESBL-Enterobacteriaceae Infections
Completed NCT04319328 - Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
Completed NCT04613271 - Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia Phase 3
Completed NCT03239665 - Vaccination Education Through Pharmacists and Senior Centers (VEPSC) N/A
Completed NCT03224026 - Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source
Not yet recruiting NCT06102070 - Genetic Susceptibility to Severe Infections